- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 155.65M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $39.76K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $193K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.71M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.72M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.74M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $66.32K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $225.27K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.48M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.55M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 153.15M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$418.25K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$1.6M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$1.27M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $146.96K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $86.92K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$736.38K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.77K |